insights_auto
Why is SHTDF up 2.98%?
Dive Deeperchevron_right
SHTDF:OTCMKTS
Sinopharm Group Co Ltd
$1.93
arrow_upward
+2.98%(+0.056) 1D
Oct 5, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SHTDF...
Open
$1.92
High
$1.93
Low
$1.92
Mkt. cap
46.56B
Avg. vol.
57.66K
Volume
3.05K
52-wk high
$2.70
52-wk low
$1.72
Beta
0.67
Shares outstanding
1.34B
No. of employees
90K
Open
$1.92
High
$1.93
Low
$1.92
Mkt. cap
46.56B
Avg. vol.
57.66K
Volume
3.05K
52-wk high
$2.70
52-wk low
$1.72
Beta
0.67
Shares outstanding
1.34B
No. of employees
90K
News stories
From web sources and news partners
Business Wire
·
53 minutes ago
Everspin Technologies to Ring Opening Bell in Celebration of 10-Year Nasdaq Anniversary
The Manila Times
·
9 minutes ago
ONAR Appoints Audit Chair Kelly Anderson, Former Public-Company CFO and Veteran of More Than 400 Acquisitions, as Interim Chief Financial Officer to Lead Nasdaq Uplist Preparation
www.marketscreener.com
·
23 minutes ago
XCF Global (Nasdaq:SAFX) Stockholders Approve Proposed Business Combination with DevvStream and Southern Energy Renewables
Profile
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
About Sinopharm Group Co Ltd